Google Find us on Google+

Report: Patient advocacy groups pushed opioids after getting industry money

Feb 13, 2018 by

Photo by freestocks.org on Unsplash

Opioid manufacturers funneled millions of dollars to patient advocacy groups that pushed “opioid friendly” messages

Opioid manufacturers funneled millions of dollars to patient advocacy groups that in turn issued “opioid friendly” guidance and policy recommendations, a congressional report has found.

Five major pharmaceutical manufacturers paid nearly $10 million to 14 patient advocacy groups and medical professional societies — as well as affiliated doctors — who were working on opioid-related issues between 2012 and 2017, according to the report released on Monday by Missouri Sen. Claire McCaskill, the Senate Homeland Security & Governmental Affairs Committee’s top Democrat.

After receiving the donations, these groups and and professional societies minimized the risk of addiction, promoted opioid use, lobbied against legislation that would curb abuse and fought attempts to hold physicians and industry executives responsible for over-prescribing opioids, the report maintains.

Source: Report: Patient advocacy groups pushed opioids after getting industry money | Lexington Herald Leader

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

UA-24036587-1